Insulet Corp PODD

NASDAQ US Health Care

$132.84 ▼ -0.20% ($-0.27)

Index member: S&P 500

Open $132.58

Prev Close $133.11

Day Range $130.80 – $133.49

52W Range $126.40 – $354.88

Market Cap $9.44B

P/E (TTM) 24.41

Beta 1.09

EPS (TTM) $5.35

📋 Company Profile

Industry	Health Care
Country	US
Exchange	NASDAQ NMS - GLOBAL MARKET
Currency	USD
IPO Date	2007-05-15
Shares Out.	69,260,000
Website	omnipod.com ↗
Phone	18668207754
Employees	5,400
Revenue	$801.7M
Gross Profit	$562.6M
Net Income	$95.0M
Free Cash Flow	$282.5M
Total Assets	$3.17B
Total Liabilities	$1.74B
Equity	$1.42B

About Insulet Corp

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, more than 600,000 insulin-dependent diabetic patients are using it worldwide.

Insulet Corp is a publicly traded company under the ticker symbol PODD on the NASDAQ NMS - GLOBAL MARKET, operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.